Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
1966 6
1967 13
1968 32
1969 49
1970 33
1971 67
1972 66
1973 78
1974 92
1975 101
1976 84
1977 77
1978 98
1979 86
1980 111
1981 92
1982 97
1983 101
1984 106
1985 126
1986 123
1987 138
1988 144
1989 162
1990 165
1991 165
1992 166
1993 186
1994 210
1995 203
1996 193
1997 236
1998 275
1999 304
2000 311
2001 386
2002 433
2003 500
2004 489
2005 568
2006 632
2007 603
2008 669
2009 672
2010 719
2011 786
2012 811
2013 853
2014 872
2015 843
2016 874
2017 914
2018 963
2019 972
2020 1092
2021 1149
2022 1115
2023 1089
2024 459

Text availability

Article attribute

Article type

Publication date

Search Results

21,121 results

Results by year

Filters applied: . Clear all
Page 1
Minocycline and Doxycycline: More Than Antibiotics.
Singh S, Khanna D, Kalra S. Singh S, et al. Curr Mol Pharmacol. 2021;14(6):1046-1065. doi: 10.2174/1874467214666210210122628. Curr Mol Pharmacol. 2021. PMID: 33568043 Review.
Minocycline and doxycycline both are second-generation tetracycline antibiotics with similar chemical structures and comparable antibacterial spectrum. ...Non-antibiotic biological effects for both the antibiotics were identified through searching relevant databases includ …
Minocycline and doxycycline both are second-generation tetracycline antibiotics with similar chemical structures and comparable antib …
Doxycycline.
Cunha BA, Sibley CM, Ristuccia AM. Cunha BA, et al. Ther Drug Monit. 1982;4(2):115-35. doi: 10.1097/00007691-198206000-00001. Ther Drug Monit. 1982. PMID: 7048645 Review.
The chemistry, mode of action, antimicrobial activity, pharmacokinetics, and therapeutic efficacy of doxycycline are reviewed. Doxycycline displays excellent activity against gram-positive and gram-negative aerobic and anaerobic pathogens. ...Because of the prolonge …
The chemistry, mode of action, antimicrobial activity, pharmacokinetics, and therapeutic efficacy of doxycycline are reviewed. Dox …
Doxycycline: An option in the treatment of ulcerated oral lesions?
Piacentini M, Borghetti RL, Zancanaro de Figueiredo MA, Cherubini K, Gonçalves Salum F. Piacentini M, et al. J Clin Pharm Ther. 2019 Dec;44(6):838-843. doi: 10.1111/jcpt.13022. Epub 2019 Aug 10. J Clin Pharm Ther. 2019. PMID: 31400293 Review.
Controlled, randomized clinical trials were selected. The concentration of doxycycline, frequency of application, pain relief and clinical remission of the lesions were analysed. ...WHAT IS NEW AND CONCLUSION: The present study suggests that topical doxycycline has …
Controlled, randomized clinical trials were selected. The concentration of doxycycline, frequency of application, pain relief and cli …
Doxycycline revisited.
Joshi N, Miller DQ. Joshi N, et al. Arch Intern Med. 1997 Jul 14;157(13):1421-8. Arch Intern Med. 1997. PMID: 9224219 Review.
In today's era of cost containment, it is particularly relevant to revisit older, inexpensive antibiotics to reexplore their role in the face of the emergence of resistant microorganisms and competition from newer agents. Doxycycline is one such antibiotic. It is an inexpe …
In today's era of cost containment, it is particularly relevant to revisit older, inexpensive antibiotics to reexplore their role in the fac …
Doxycycline as Potential Anti-cancer Agent.
Ali I, Alfarouk KO, Reshkin SJ, Ibrahim ME. Ali I, et al. Anticancer Agents Med Chem. 2017;17(12):1617-1623. doi: 10.2174/1871520617666170213111951. Anticancer Agents Med Chem. 2017. PMID: 28270076 Review.
In this article, we try to introduce a new concept of cancer pharmacology, by offering new off-label use of Doxycycline, which is characterized by selective toxicity, as potential anticancer agents. ...
In this article, we try to introduce a new concept of cancer pharmacology, by offering new off-label use of Doxycycline, which is cha …
[Doxycycline].
Bonnetblanc JM. Bonnetblanc JM. Ann Dermatol Venereol. 2002 Jun-Jul;129(6-7):874-82. Ann Dermatol Venereol. 2002. PMID: 12218915 Review. French.
Doxycyclin is a semi-synthetic structural isomer of the tetracycline family. ...Doxycyclin is rapidly and almost completely absorbed by the digestive tract. ...
Doxycyclin is a semi-synthetic structural isomer of the tetracycline family. ...Doxycyclin is rapidly and almost completely ab …
[Doxycycline--the forgotten antibiotic].
Ziegler T, Winkler C, Wege K, Schmechel H. Ziegler T, et al. Med Klin (Munich). 2000 Nov 15;95(11):629-31. doi: 10.1007/pl00002075. Med Klin (Munich). 2000. PMID: 11143543 Review. German.
BACKGROUND: Doxycycline is an broad-spectrum antimicrobial agent, it remains an inexpensive alternative for the treatment of community-acquired respiratory infections and urinary tract infections. ...Doxycycline is the drug of choice for treating infections caused b …
BACKGROUND: Doxycycline is an broad-spectrum antimicrobial agent, it remains an inexpensive alternative for the treatment of communit …
Doxycycline in serum and bronchial secretions.
Hartnett BJ, Marlin GE. Hartnett BJ, et al. Thorax. 1976 Apr;31(2):144-8. doi: 10.1136/thx.31.2.144. Thorax. 1976. PMID: 821169 Free PMC article. Review.
The concentration of doxycycline hydrochloride was measured in serum and bronchial secretions in five patients with chronic bronchitis receiving doxycycline orally in normal therapeutic dosage for seven days (200 mg day 1, 100 mg days 2 to 7). ...There was no correl …
The concentration of doxycycline hydrochloride was measured in serum and bronchial secretions in five patients with chronic bronchiti …
Doxycycline post exposure prophylaxis could select for cross-resistance to other antimicrobials in various pathogens: An in silico analysis.
Gestels Z, Manoharan-Basil SS, Kenyon C. Gestels Z, et al. Int J STD AIDS. 2023 Nov;34(13):962-968. doi: 10.1177/09564624231190108. Epub 2023 Jul 19. Int J STD AIDS. 2023. PMID: 37466467
BACKGROUND: A number of randomized controlled trials have found that doxycycline post exposure prophylaxis (PEP) can reduce the incidence of gonorrhoea, chlamydia and syphilis in men who have sex with men (MSM). ...CONCLUSION: These results suggest that studies evaluating …
BACKGROUND: A number of randomized controlled trials have found that doxycycline post exposure prophylaxis (PEP) can reduce the incid …
Doxycycline prevents blood-brain barrier dysfunction and microvascular hyperpermeability after traumatic brain injury.
Robinson BD, Isbell CL, Melge AR, Lomas AM, Shaji CA, Mohan CG, Huang JH, Tharakan B. Robinson BD, et al. Sci Rep. 2022 Mar 30;12(1):5415. doi: 10.1038/s41598-022-09394-4. Sci Rep. 2022. PMID: 35354869 Free PMC article.
Doxycycline treatment decreased BBB hyperpermeability following TBI in mice by 25% (p < 0.05). MMP-9 enzyme activity in brain tissue decreased with doxycycline treatment following TBI (p < 0.05). Doxycycline preserves BBB tight junction integrity follow …
Doxycycline treatment decreased BBB hyperpermeability following TBI in mice by 25% (p < 0.05). MMP-9 enzyme activity in brain tiss …
21,121 results
You have reached the last available page of results. Please see the User Guide for more information.